Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain

PURPOSE: To perform a cost-effectiveness analysis of radium-223 plus Best Supportive Care (BSC) compared to BSC in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and without previous docetaxel treatment in Spain. DESIGN AND METHODS: A Markov model was develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirado Mercier, Eva, Callejo Velasco, Daniel, Rubio Cabezas, Marta, Moretones Agut, Cristina, Granell Villalón, Meritxell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309959/
https://www.ncbi.nlm.nih.gov/pubmed/32685568
http://dx.doi.org/10.36469/9777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309959/
https://www.ncbi.nlm.nih.gov/pubmed/32685568
http://dx.doi.org/10.36469/9777

Ejemplares similares